Journal of Molecular and Cellular Cardiology
Volume 46, Issue 3 , Pages 385-394 , March 2009

Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation

  • Maura Greiser

      Affiliations

    • Department of Physiology, University Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 43 3881320; fax: +31 43 3884166.
    • M.G. and H.R.N. contributed equally to this work.
    • ,
  • Hans-Ruprecht Neuberger

      Affiliations

    • Department of Physiology, University Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands
    • Klinik für Innere Medizin III, Universität des Saarlandes, Homburg/Saar, Germany
    • M.G. and H.R.N. contributed equally to this work.
    • ,
  • Erik Harks

      Affiliations

    • Department of Physiology, University Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Ali El-Armouche

      Affiliations

    • Institute of Experimental and Clinical Pharmacology and Toxicology, Medical Center Hamburg-Eppendorf, Germany
    • ,
  • Peter Boknik

      Affiliations

    • Department of Pharmacology and Toxicology, University of Münster, Münster, Germany
    • ,
  • Sunniva de Haan

      Affiliations

    • Department of Physiology, University Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Fons Verheyen

      Affiliations

    • Department of Molecular Cell Biology, University Maastricht, Maastricht, The Netherlands
    • ,
  • Sander Verheule
    • ,
  • Wilhelm Schmitz

      Affiliations

    • Department of Pharmacology and Toxicology, University of Münster, Münster, Germany
    • ,
  • Ursula Ravens
    • ,
  • Stanley Nattel

      Affiliations

    • Research Center, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • ,
  • Maurits A. Allessie

      Affiliations

    • Department of Physiology, University Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Dobromir Dobrev

      Affiliations

    • Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany
    • U.S. and D.D. share senior authorship.
    • ,
  • Ulrich Schotten

      Affiliations

    • Department of Physiology, University Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands
    • Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany
    • U.S. and D.D. share senior authorship.

Received 10 June 2008 ,Revised 21 October 2008 ,Accepted 3 November 2008.

References 

  1. Gorelick PB. Stroke prevention. An opportunity for efficient utilization of health care resources during the coming decade. Stroke. 1994;25:220–224
  2. Petty GW, Brown RD, Whisnant JP, Sicks JD, OÆFallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999;30:2513–2516
  3. Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke. 1999;30:2019–2024
  4. Cabin HS, Clubb KS, Hall C, Perlmutter RA, Feinstein AR. Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am. J. Cardiol. 1990;65:1112–1116
  5. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation. 1995;92:835–841
  6. Shi Y, Ducharme A, Li D, Gaspo R, Nattel S, Tardif JC. Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc. Res. 2001;52:217–225
  7. Sparks PB, Mond HG, Vohra JK, Yapanis AG, Grigg LE, Kalman JM. Mechanical remodeling of the left atrium after loss of atrioventricular synchrony — a long-term study in humans. Circulation. 1999;100:1714–1721
  8. Schotten U, Duytschaever M, Ausma J, Eijsbouts S, Neuberger HR, Allessie M. Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation. 2003;107:1433–1439
  9. Schotten U, Greiser M, Benke D, Buerkel K, Ehrenteidt B, Stellbrink C, et al. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc. Res. 2002;53:192–201
  10. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104:174–180
  11. Kneller J, Sun H, Leblanc N, Nattel S. Remodeling of Ca2+-handling by atrial tachycardia: evidence for a role in loss of rate-adaptation. Cardiovasc. Res. 2002;54:416–426
  12. Schotten U, Ausma J, Stellbrink C, Sabatschus I, Vogel M, Frechen D, et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation. 2001;103:691–698
  13. Deroubaix E, Folliguet T, Rücker-Martin C, Dinanian S, Boixel C, Validire P, et al. Moderate and chronic hemodynamic overload of sheep atria induces reversible cellular electrophysiologic abnormalities and atrial vulnerability. J. Am. Coll. Cardiol. 2004;44:1918–1926
  14. Neuberger HR, Schotten U, Verheule S, Eijsbouts S, Blaauw Y, van Hunnik A, et al. Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat. Circulation. 2005;111:30–37
  15. Verheule S, Wilson E, Banthia S, Everett TH, Shanbhag S, Sih HJ, et al. Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation. Am. J. Physiol. Heart Circ. Physiol. 2004;287:H634–644
  16. de Haan S, Greiser M, Harks E, Blaauw Y, van Hunnik A, Verheule S, et al. AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat. Circulation. 2006;114:1234–1242
  17. Ausma J, Wijffels M, Thoné F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 1997;96:3157–3163
  18. Hryshko LV, Stiffel V, Bers DM. Rapid cooling contractures as an index of sarcoplasmic reticulum calcium content in rabbit ventricular myocytes. Am. J. Physiol. 1989;257:H1369–1377
  19. Popov N, Schmitt M, Schulzeck S, Matthies H. Reliable micromethod for determination of the protein content in tissue homogenates. Acta Biol. Med. Ger. 1975;34:1441–1446
  20. El Armouche A, Boknik P, Eschenhagen T, Carrier L, Knaut M, Ravens U, et al. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation. 2006;114:670–680
  21. Boknik P, Fockenbrock M, Herzig S, Knapp J, Linck B, Luss H, et al. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn- Schmiedeberg's Arch. Pharmacol. 2000;362:222–231
  22. Christ T, Boknik P, Wohrl S, Wettwer E, Graf EM, Bosch RF, et al. L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation. 2004;110:2651–2657
  23. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ. Res. 1997;81:512–525
  24. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kühlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc. Res. 1999;44:121–131
  25. Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A, et al. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation. 2000;101:2631–2638
  26. Röcken C, Peters B, Juenemann G, Saeger W, Klein HU, Huth C, et al. Attrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation. 2002;106:2091–2097
  27. Ausma J, Litjens N, Lenders MH, Duimel H, Mast F, Wouters L, et al. Time course of atrial fibrillation-induced cellular structural remodeling in Atria of the goat. J. Mol. Cell. Cardiol. 2001;33:2083–2094
  28. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force 2nd edition Dordrecht. the Netherlands: Kluwer; 2001;
  29. Bers DM. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda). 2006;21:380–387
  30. Stelzer JE, Patel JR, Moss RL. Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of cMyBP-C. Circ. Res. 2006;99:884–890
  31. El-Armouche A, Pohlmann L, Schlossarek S, Starbatty J, Yeh YH, Nattel S, et al. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J. Mol. Cell. Cardiol. 2007;43:223–229
  32. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365–376
  33. Hove-Madsen L, Llach A, Bayes-Genis A, Roura S, Rodriguez FE, Aris A, et al. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation. 2004;110:1358–1363
  34. Maclennan DH, Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev Mol. Cell Biol. 2003;4:566–577
  35. Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P, et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation. 2005;111:2025–2032
  36. Yeh YH, Wakili R, Qi XY, Chartier D, Boknik P, Kääb S, et al. Calcium handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ. Arrhythmia Electrophysiol. 2008;1:93–102
  37. Narolska NA, Eiras S, van Loon RB, Boontje NM, Zaremba R, Spiegelen B, et al. Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium. J. Muscle Res. Cell Motil. 2005;26:39–48
  38. Eiras S, Narolska NA, van Loon RB, Boontje NM, Zaremba R, Jimenez CR, et al. Alterations in contractile protein composition and function in human atrial dilatation and atrial fibrillation. J. Mol. Cell. Cardiol. 2006;41:467–477

PII: S0022-2828(08)01403-X

doi: 10.1016/j.yjmcc.2008.11.012

Journal of Molecular and Cellular Cardiology
Volume 46, Issue 3 , Pages 385-394 , March 2009

Article Tools

* Image Usage & Resolution